Researchers Find Lecanemab Falls Short in Alzheimer’s Treatment
A study conducted by researchers at Osaka Metropolitan University reveals that lecanemab, an amyloid-clearing drug designed for Alzheimer’s treatment, does not enhance the brain’s waste clearance system in the short…